| |
| |
|
| Insider
Information: |
Robinson Kenneth S |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
44,105 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,110 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,105 |
|
|
| Total
Value |
$15,110 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Director |
2018-10-01 |
44,105 |
2008-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2018-10-01 |
4 |
A |
$1.50 |
$13,375 |
D/D |
8,917 |
44,105 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2018-07-02 |
4 |
A |
$15.47 |
$13,375 |
D/D |
865 |
35,189 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2018-04-02 |
4 |
A |
$17.47 |
$13,375 |
D/D |
766 |
34,324 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2018-01-02 |
4 |
A |
$11.46 |
$13,375 |
D/D |
1,167 |
33,558 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2017-10-02 |
4 |
A |
$7.94 |
$13,375 |
D/D |
1,685 |
32,391 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2017-04-03 |
4 |
A |
$4.90 |
$13,375 |
D/D |
2,730 |
28,164 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2017-01-03 |
4 |
A |
$5.21 |
$13,375 |
D/D |
2,567 |
25,434 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2016-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,599 |
228,672 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,318 |
211,074 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2016-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,884 |
186,755 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
18,838 |
162,872 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2015-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,500 |
144,034 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,195 |
127,534 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
119,338 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,833 |
100,588 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,240 |
85,755 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2014-07-01 |
4 |
A |
$1.39 |
$11,125 |
D/D |
8,004 |
70,515 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2014-04-01 |
4 |
A |
$1.56 |
$11,125 |
D/D |
7,131 |
62,511 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2014-01-02 |
4 |
A |
$1.68 |
$11,125 |
D/D |
6,622 |
55,380 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2013-10-01 |
4 |
A |
$1.87 |
$11,125 |
D/D |
5,949 |
48,758 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2013-07-01 |
4 |
A |
$6.62 |
$11,125 |
D/D |
1,681 |
42,809 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2013-04-01 |
4 |
A |
$4.04 |
$11,125 |
D/D |
2,754 |
41,128 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2013-01-01 |
4 |
A |
$4.20 |
$13,125 |
D/D |
3,125 |
38,375 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2012-10-01 |
4 |
A |
$4.58 |
$8,250 |
D/D |
1,801 |
35,250 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2012-07-01 |
4 |
A |
$3.52 |
$9,000 |
D/D |
2,557 |
33,448 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
